RABELLE TALREJA: Open Payments
NPI 1417537887 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $398 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 3 | $58 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Neuronetics, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: Cologuard Collection Kit, TRELEGY ELLIPTA, AIRSUPRA, OPSUMIT, OTEZLA, Rybelsus, ELIQUIS, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across FL — which companies pay providers there.
